Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Apimeds Pharmaceuticals US, Inc. (APUS) had Return on Equity of -27.34% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$2.66M |
|
$-2.66M |
|
$0.00M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
10.37M |
|
10.37M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$10.35M |
|
$0.01M |
|
$0.20M |
|
$10.55M |
|
$0.81M |
|
-- |
|
-- |
|
$0.81M |
|
$9.74M |
|
$9.74M |
|
$9.74M |
|
12.58M |
|
| Cash Flow Statement Financials | |
$-3.38M |
|
$-0.01M |
|
$12.13M |
|
$0.00M |
|
$8.74M |
|
$8.73M |
|
$1.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.79 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.39M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-27.34% |
-27.34% |
|
-25.24% |
|
-27.34% |
|
$0.77 |
|
$-0.33 |
|
$-0.33 |
|